Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions


Answer 1
  1. Trimethoprim-sulfamethoxazole therapy. Trimethoprim-sulfamethoxazole (TMP-SMX), which is structurally similar to amiloride, causes hyperkalemia by blocking the apical membrane sodium channel in the principal cell (similar to amiloride and triamterene). Significantly, hyperkalemia occurs with high-dose TMP-SMX in patients with AIDS and with standard-dose TMP-SMX in patients with mild renal impairment. Adrenal insufficiency is more classically associated with hyperkalemia, hyponatremia, and hypotension. The level of hyperkalemia in this patient is excessive for the modest change in serum creatinine, which is elevated from the effect of trimethoprim to competitively inhibit proximal tubular creatinine secretion.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj